PRT Versus IMRT Toxicity In Medicare Beneficiaries With Prostate Cancer
12/21/2012
There is no difference between proton radiotherapy (PRT) and intensity-modulated radiotherapy (IMRT) when comparing the toxicity among Medicare beneficiary patients with prostate cancer at 12 months post-treatment according to a study published December 14 in the Journal of the National Cancer Institute...
A Genetic Defect In Sex Cells May Predispose To Childhood Leukemia
12/21/2012
Researchers at the Sainte-Justine University Hospital Center and the University of Montreal have found a possible heredity mechanism that predisposes children to acute lymphoblastic leukemia (ALL), the most common type of blood cancer in children...
Mayo Clinic Study Unmasks Regulator Of Healthy Life Span
12/21/2012
A new series of studies in mouse models by Mayo Clinic researchers uncovered that the aging process is characterized by high rates of whole-chromosome losses and gains in various organs, including heart, muscle, kidney and eye, and demonstrate that reducing these rates slows age-related tissue deterioration and promotes a healthier life span...
New Technology May Enable Earlier Cancer Diagnosis
12/21/2012
Finding ways to diagnose cancer earlier could greatly improve the chances of survival for many patients. One way to do this is to look for specific proteins secreted by cancer cells, which circulate in the bloodstream. However, the quantity of these biomarkers is so low that detecting them has proven difficult...
Improving Cell-Based Immune Therapies For Cancer
12/21/2012
A team led by Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering at Memorial Sloan-Kettering Cancer Center, has shown for the first time the effectiveness of a new technique that could allow the development of more-specific, cell-based immune therapies for cancer. Their findings were reported online in Nature Biotechnology...
Scientists Find Gene Linked To Ovarian And Breast Cancer
12/21/2012
Mutations in a gene known as PPM1D are associated with a higher risk of breast and ovarian cancer - which may represent a new cancer-causing process. The finding came from a new study published in the journal Nature which was conducted by a team of experts from The Institute of Cancer Research, London...
New Molecule Linked To Late-Stage Breast Cancer Discovered
12/21/2012
Researchers at Case Western Reserve University School of Medicine have identified a molecule linked to more aggressive forms of breast cancer - a discovery that could point the way to potential cures. Until this study, the ribonucleic acid (RNA) molecule called miR-181a had never before been tied to breast cancer metastasis...
GSK Revolade® (Eltrombopag) Receives Provisional NICE Recommendation For Treatment Of Chronic ITP
12/21/2012
Once-daily oral treatment offers patients a clinically and cost-effective option Patients in England and Wales living with an immune disorder causing low blood platelet count, known as " cITP", chronic immune (idiopathic) thrombocytopenic purpura, are one step closer to being able to access Revolade® (eltrombopag) on the National Health Service (NHS)...
Scientists Find Gene Linked To Ovarian And Breast Cancer
12/21/2012
Mutations in a gene known as PPM1D are associated with a higher risk of breast and ovarian cancer - which may represent a new cancer-causing process. The finding came from a new study published in the journal Nature which was conducted by a team of experts from The Institute of Cancer Research, London...
A Genetic Defect In Sex Cells May Predispose To Childhood Leukemia
12/20/2012
Rare atypical forms of the PRDM9 fertility gene found in parents Researchers at the Sainte-Justine University Hospital Center and the University of Montreal have found a possible heredity mechanism that predisposes children to acute lymphoblastic leukemia (ALL), the most common type of blood cancer in children...